The present invention is concerned with isoxazole-pyridine derivatives of formula I
wherein X, R
1
to R
6
are as described herein. The compounds are active on the GABA A α5 receptor binding site and useful for the treatment of cognitive disorders, such as Alzheimer's disease.
本发明涉及式I的异恶唑-吡啶衍生物
其中X,R1至R6如本文所述。这些化合物对GABA A α5受体结合位点具有活性,并可用于治疗认知障碍,如阿尔茨海默病。
Aryl-isoxazol-4-yl-imidazole derivatives
申请人:Buettelmann Bernd
公开号:US20070161654A1
公开(公告)日:2007-07-12
The present invention is concerned with aryl-isoxazol-4-yl-imidazole derivatives of formula I:
wherein
R
1
to R
6
are as defmed in the specification and pharmaceutically acceptable acid addition salts thereof. This class of compounds has high affinity and selectivity for GABA A α5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.
本发明涉及式I的芳基异噁唑-4-基咪唑衍生物:其中R1至R6如规范中定义,并且其药用酸盐。这类化合物具有高亲和力和选择性结合到GABA A α5受体结合位点,可能有助于作为认知增强剂或治疗认知障碍如阿尔茨海默病。
PROCESS FOR THE PREPARATION OF ISOXAZOLYL- METHOXY NICOTINIC ACIDS
申请人:Hoffmann-La Roche Inc.
公开号:US20130102778A1
公开(公告)日:2013-04-25
The present invention relates to a process for the preparation of a compound of formula (I)
wherein R
1
and R
2
are as defined herein, which is useful as an intermediate in the preparation of active pharmaceutical compounds.
[EN] PROCESS FOR THE PREPARATION OF ISOXAZOLYL-METHOXY-NICOTINIC ACIDS<br/>[FR] PROCÉDÉ DE PRÉPARATION D'ACIDES ISOXAZOLYL-MÉTHOXY-NICOTINIQUES
申请人:HOFFMANN LA ROCHE
公开号:WO2013057123A1
公开(公告)日:2013-04-25
The present invention relates to a process for the preparation of a compound of formula (I) which is useful as an intermediate in the preparation of active pharmaceutical compounds from a compound of formula (IV) wherein R1 and R2 are as defined herein,.
PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF
申请人:Kim Dong Yeon
公开号:US20140031364A1
公开(公告)日:2014-01-30
Disclosed are a phenyl-isoxazol derivative compound, which is useful as a treatment material for virus infection, especially, infection of an influenza virus, or its pharmaceutically acceptable derivative, a preparation method thereof, and an illness treatment pharmaceutical composition including the compound as an active ingredient.